My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 91

    1.

    Pharmacogenetics of tolbutamide metabolism in humans.

    Scott J, Poffenbarger PL.

    Diabetes. 1979 Jan;28(1):41-51.PMID: 569611 [PubMed - indexed for MEDLINE]Related articles

    2.

    Tolbutamide pharmacogenetics and the UGDP controversy.

    Scott J, Poffenbarger PL.

    JAMA. 1979 Jul 6;242(1):45-8.PMID: 448864 [PubMed - indexed for MEDLINE]Related articles

    3.

    Polymorphism of theophylline metabolism in man.

    Miller CA, Slusher LB, Vesell ES.

    J Clin Invest. 1985 May;75(5):1415-25.PMID: 4039734 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Theophylline metabolism: variation and genetics.

    Miller M, Opheim KE, Raisys VA, Motulsky AG.

    Clin Pharmacol Ther. 1984 Feb;35(2):170-82.PMID: 6362955 [PubMed - indexed for MEDLINE]Related articles

    5.

    Alteration of drug metabolism during cholestasis in man.

    Carulli N, Manenti F, Ponz de Leon M, Ferrari A, Salvioli G, Gallo M.

    Eur J Clin Invest. 1975 Nov 21;5(6):455-62.PMID: 1201763 [PubMed - indexed for MEDLINE]Related articles

    6.

    Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.

    Penno MB, Vesell ES.

    J Clin Invest. 1983 Jun;71(6):1698-709.PMID: 6863539 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A screening test for slow metabolisers of tolbutamide.

    Page MA, Boutagy JS, Shenfield GM.

    Br J Clin Pharmacol. 1991 Jun;31(6):649-54.PMID: 1867959 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.

    Williams RL, Blaschke TF, Meffin PJ, Melmon KL, Rowland M.

    Clin Pharmacol Ther. 1977 Mar;21(3):301-9.PMID: 837649 [PubMed - indexed for MEDLINE]Related articles

    9.

    A study of the potential effect of sertraline on the pharmacokinetics and protein binding of tolbutamide.

    Tremaine LM, Wilner KD, Preskorn SH.

    Clin Pharmacokinet. 1997;32 Suppl 1:31-6.PMID: 9068933 [PubMed - indexed for MEDLINE]Related articles

    10.

    Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjects.

    Veronese ME, Miners JO, Rees DL, Birkett DJ.

    Pharmacogenetics. 1993 Apr;3(2):86-93.PMID: 8518838 [PubMed - indexed for MEDLINE]Related articles

    11.

    Inhibitory effect of nicotine and its metabolites on tolbutamide hydroxylation in rat liver microsomes.

    Leung YK, Ho JW.

    J Biochem Biophys Methods. 1998 Jun 11;36(2-3):87-94.PMID: 9711495 [PubMed - indexed for MEDLINE]Related articles

    12.

    Unaltered metabolism of antipyrine and tolbutamide in fasting man.

    Reidenberg MM, Vesell ES.

    Clin Pharmacol Ther. 1975 Jun;17(6):650-6.PMID: 1139856 [PubMed - indexed for MEDLINE]Related articles

    13.

    Clinical pharmacology of antidepressant drugs: pharmacogenetics.

    Sjöqvist F, Bertilsson L.

    Adv Biochem Psychopharmacol. 1984;39:359-72. Review.PMID: 6380229 [PubMed - indexed for MEDLINE]Related articles

    14.

    Protein binding and hepatic clearance: studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation.

    Schary WL, Rowland M.

    J Pharmacokinet Biopharm. 1983 Jun;11(3):225-43.PMID: 6644551 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)]

    Goto A.

    Nippon Naibunpi Gakkai Zasshi. 1975 Aug 20;51(8):676-84. Japanese. PMID: 1237421 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans.

    Shon JH, Yoon YR, Kim KA, Lim YC, Lee KJ, Park JY, Cha IJ, Flockhart DA, Shin JG.

    Pharmacogenetics. 2002 Mar;12(2):111-9.PMID: 11875365 [PubMed - indexed for MEDLINE]Related articles

    17.

    Serum protein binding of tolbutamide in patients treated with antiepileptic drugs.

    Fernández MC, Erill S, Lucena MI, Pita E, Pérez-Alférez N.

    Clin Pharmacokinet. 1985 Sep-Oct;10(5):451-5.PMID: 3930124 [PubMed - indexed for MEDLINE]Related articles

    18.

    Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.

    Hansen T, Echwald SM, Hansen L, Møller AM, Almind K, Clausen JO, Urhammer SA, Inoue H, Ferrer J, Bryan J, Aguilar-Bryan L, Permutt MA, Pedersen O.

    Diabetes. 1998 Apr;47(4):598-605.PMID: 9568693 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Uniform elimination pattern for glibenclamide in healthy Caucasian males.

    Spraul M, Streeck A, Nieradzik M, Berger M.

    Arzneimittelforschung. 1989 Nov;39(11):1449-50.PMID: 2515863 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pharmacogenetics of nicotine metabolism in twins: methods and procedures.

    Swan GE, Benowitz NL, Jacob P 3rd, Lessov CN, Tyndale RF, Wilhelmsen K, Krasnow RE, McElroy MR, Moore SE, Wambach M.

    Twin Res. 2004 Oct;7(5):435-48.PMID: 15527659 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity